JESSICA DONAHUE: Open Payments
NPI 1497131890 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 55 payments from 22 companies in 2025. Trend: 2023 $1,868 · 2024 $1,843 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 7 | $268 |
| AstraZeneca Pharmaceuticals LP | 2 | $210 |
| ABBVIE INC. | 11 | $201 |
| PFIZER INC. | 3 | $63 |
| Amgen Inc. | 3 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Exact Sciences Corporation | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
Products named: AIRSUPRA, Biktarvy, VRAYLAR, Kerendia, PREVNAR 20, OTEZLA, XIFAXAN, REXULTI.
Industry payments across CO — which companies pay providers there.
